PGR.F
Progress Software Corporation
FrankfurtEUREQUITY
Technology
DELAYED
Last price
36.80
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
36.80
Day high
36.80
Day low
36.80
Volume
95
Market cap
$1.51B
P/E (TTM)
20.91
52W range
21.20 – 40.20
Trailing performance
Returnvs SPY
1W
-4.66%
-3.3%
1M
+11.52%
+7.8%
3M
+42.64%
+39.5%
6M
+7.60%
-3.5%
YTD
0.00%
-12.3%
1Y
-4.66%
-24.7%
3Y
-35.44%
-109.6%
5Y
-5.64%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PGR.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
926.48K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | FOLGER ANTHONY Chief Financial Officer |
SELL | 2.00K | $89.60K | Direct |
| Jul 29, 26 | JARRETT LOREN Officer |
SELL | 11.75K | $488.78K | Direct |
| Jul 2, 26 | GAWLICK RAINER Director |
STOCK | 5.86K | $225.03K | Direct |
| Jul 2, 26 | TUCCI ANGELA Director |
STOCK | 5.86K | $225.03K | Direct |
| Jul 2, 26 | KING SAMSKRITI Director |
STOCK | 5.86K | $225.03K | Direct |
| Jul 2, 26 | DACIER PAUL T Director |
STOCK | 5.86K | $225.03K | Direct |
| Jul 2, 26 | EGAN JOHN R Director |
STOCK | 5.86K | $225.03K | Direct |
| Jul 2, 26 | KANE CHARLES FRANCIS Director |
STOCK | 5.86K | $225.03K | Direct |
| Jul 2, 26 | KRALL DAVID A Director |
STOCK | 5.86K | $225.03K | Direct |
| Jul 2, 26 | VITALE VIVIAN M Director |
STOCK | 5.86K | $225.03K | Direct |
| Jul 1, 26 | SUBRAMANIAN SUNDAR Officer |
SELL | 10.60K | $405.55K | Direct |
| Jul 1, 26 | SUBRAMANIAN SUNDAR Officer |
CONVERSION | 10.60K | $403.32K | Direct |
| May 19, 26 | FOLGER ANTHONY Chief Financial Officer |
SELL | 4.47K | $130.33K | Direct |
| May 18, 26 | WANG YUFAN STEPHANIE Officer |
SELL | 5.02K | $144.85K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
AINSWORTH JOHN |
Officer | 58.12K | Conversion of Exercise of derivative security |
DACIER PAUL T |
Director | 58.69K | Stock Award(Grant) |
EGAN JOHN R |
Director | 57.17K | Stock Award(Grant) |
FOLGER ANTHONY |
Chief Financial Officer | 47.38K | Sale |
GAWLICK RAINER |
Director | 61.40K | Stock Award(Grant) |
GUPTA YOGESH K. |
Chief Executive Officer | 286.20K | Conversion of Exercise of derivative security |
KANE CHARLES FRANCIS |
Director | 76.29K | Stock Award(Grant) |
KING SAMSKRITI |
Director | 51.12K | Stock Award(Grant) |
KRALL DAVID A |
Director | 105.95K | Stock Award(Grant) |
TUCCI ANGELA |
Director | 51.12K | Stock Award(Grant) |
Fundamentals
Market cap$1.51B
Enterprise value$2.73B
Revenue (TTM)$1.00B
Gross profit$858.88M
EBITDA$333.75M
Net income$89.04M
EPS (TTM)$1.76
Free cash flow$307.68M
Total cash$102.98M
Total debt$1.33B
Book value / share$10.58
Shares outstanding41.01M
Float40.34M
Short % of float—
Dividend yield—
Beta (5Y)0.81
Valuation & profitability ratios
Trailing P/E20.91
Forward P/E9.20
PEG ratio1.37
Price / sales—
Price / book3.48
EV / revenue2.72
EV / EBITDA8.19
Gross margin85.57%
Operating margin18.55%
Profit margin8.87%
Return on equity18.57%
Return on assets4.89%
Debt / equity262.16
Current ratio0.81
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $977.83M | $753.41M | $694.44M | $602.01M | +29.8% |
| Operating revenue | $977.83M | $753.41M | $694.44M | $602.01M | +29.8% |
| Cost of revenue | $187.58M | $130.48M | $126.58M | $94.50M | +43.8% |
| Gross profit | $790.25M | $622.93M | $567.86M | $507.52M | +26.9% |
| Research & development | $192.26M | $146.34M | $132.40M | $114.57M | +31.4% |
| Selling, general & admin | $319.23M | $254.09M | $239.23M | $218.64M | +25.6% |
| Total operating expense | $615.76M | $465.72M | $438.06M | $380.07M | +32.2% |
| Operating income | $174.49M | $157.21M | $129.80M | $127.44M | +11.0% |
| Net interest income | -$69.09M | -$27.28M | -$28.24M | -$14.38M | -153.3% |
| Pre-tax income | $81.63M | $94.26M | $79.66M | $117.25M | -13.4% |
| Tax provision | $8.49M | $25.83M | $9.46M | $22.19M | -67.1% |
| Net income | $73.13M | $68.44M | $70.20M | $95.07M | +6.9% |
| Net income to common | $73.13M | $68.44M | $70.20M | $95.07M | +6.9% |
| Basic EPS | 1.70 | 1.58 | 1.62 | 2.19 | +7.6% |
| Diluted EPS | 1.66 | 1.54 | 1.57 | 2.15 | +7.8% |
| EBIT | $152.48M | $126.28M | $110.44M | $133.04M | +20.7% |
| EBITDA | $304.20M | $229.32M | $213.58M | $207.78M | +32.7% |
| Basic shares | 43.00M | 43.27M | 43.46M | 43.48M | -0.6% |
| Diluted shares | 44.02M | 44.43M | 44.66M | 44.25M | -0.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $94.81M | $118.08M | $126.96M | $256.28M | — | -19.7% |
| Cash & short-term investments | $94.81M | $118.08M | $126.96M | $256.28M | — | -19.7% |
| Accounts receivable | $195.78M | $163.57M | $125.83M | $97.83M | — | +19.7% |
| Total current assets | $399.96M | $368.81M | $330.79M | $426.05M | — | +8.4% |
| Property, plant & equipment | $39.54M | $44.64M | $33.94M | $32.50M | — | -11.4% |
| Goodwill & intangibles | $1.89B | $2.02B | $1.19B | $888.39M | — | -6.1% |
| Total assets | $2.46B | $2.53B | $1.60B | $1.41B | — | -2.7% |
| Total current liabilities | $809.73M | $455.14M | $352.12M | $318.00M | — | +77.9% |
| Current debt | $359.16M | — | $13.11M | $6.23M | $25.77M | — |
| Long-term debt | $1.04B | $1.53B | $710.88M | $611.85M | — | -31.8% |
| Total debt | $1.43B | $1.56B | $747.11M | $640.59M | — | -8.4% |
| Total liabilities | $1.98B | $2.09B | $1.14B | $1.01B | — | -5.2% |
| Retained earnings | $127.37M | $120.41M | $120.86M | $101.66M | — | +5.8% |
| Shareholder equity | $478.35M | $438.79M | $459.71M | $398.50M | — | +9.0% |
| Working capital | -$409.77M | -$86.33M | -$21.33M | $108.05M | — | -374.6% |
| Net tangible assets | -$1.41B | -$1.58B | -$726.66M | -$489.89M | — | +10.3% |
| Shares issued | 42.34M | 43.36M | 43.80M | 43.26M | — | -2.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $73.13M | $68.44M | $70.20M | $95.07M | +6.9% |
| Depreciation & amortisation | $151.72M | $103.04M | $103.15M | $74.73M | +47.2% |
| Stock-based compensation | $64.77M | $46.76M | $40.53M | $37.09M | +38.5% |
| Change in working capital | -$52.54M | -$14.79M | -$23.34M | -$7.03M | -255.3% |
| Operating cash flow | $235.19M | $211.49M | $173.92M | $192.16M | +11.2% |
| Capital expenditure | -$5.70M | -$5.21M | -$5.57M | -$6.09M | -9.5% |
| Investing cash flow | -$26.92M | -$857.91M | -$360.38M | $21.99M | +96.9% |
| Share buybacks | -$105.16M | -$86.78M | -$33.96M | -$77.04M | -21.2% |
| Dividends paid | -$786.00K | -$31.46M | -$31.55M | -$31.06M | +97.5% |
| Financing cash flow | -$238.37M | $640.82M | $51.19M | -$101.42M | -137.2% |
| Free cash flow | $229.49M | $206.29M | $168.35M | $186.07M | +11.2% |
| End cash position | $94.81M | $118.08M | $126.96M | $256.28M | -19.7% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $253.47M | $247.80M | $252.67M | $249.79M | $237.35M | +2.3% |
| Operating revenue | $253.47M | $247.80M | $252.67M | $249.79M | $237.35M | +2.3% |
| Cost of revenue | $44.87M | $43.86M | $46.53M | $47.54M | $47.29M | +2.3% |
| Gross profit | $208.59M | $203.94M | $206.14M | $202.26M | $190.07M | +2.3% |
| Research & development | $48.84M | $50.47M | $49.89M | $49.43M | $46.57M | -3.2% |
| Selling, general & admin | $86.58M | $78.50M | $86.84M | $80.16M | $75.31M | +10.3% |
| Total operating expense | $161.58M | $154.59M | $162.71M | $156.00M | $147.95M | +4.5% |
| Operating income | $47.01M | $49.34M | $43.44M | $46.25M | $42.12M | -4.7% |
| Net interest income | -$15.68M | -$14.93M | -$15.83M | -$17.48M | -$17.84M | -5.0% |
| Pre-tax income | $28.84M | $30.29M | $22.26M | $26.21M | $19.86M | -4.8% |
| Tax provision | $7.77M | $7.48M | -$3.49M | $6.79M | $2.83M | +3.9% |
| Net income | $21.07M | $22.81M | $25.75M | $19.41M | $17.03M | -7.6% |
| Net income to common | $21.07M | $22.81M | $25.75M | $19.41M | $17.03M | -7.6% |
| Basic EPS | 0.50 | 0.54 | 0.60 | 0.45 | 0.40 | -7.4% |
| Diluted EPS | 0.50 | 0.53 | 0.59 | 0.44 | 0.39 | -5.7% |
| EBIT | $44.75M | $45.54M | $38.80M | $43.94M | $38.00M | -1.7% |
| EBITDA | $81.62M | $81.40M | $74.69M | $83.03M | $76.55M | +0.3% |
| Basic shares | 41.90M | 42.16M | 42.69M | 42.99M | 43.05M | -0.6% |
| Diluted shares | 42.31M | 42.73M | 43.31M | 43.72M | 44.16M | -1.0% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $102.98M | $113.17M | $94.81M | $99.01M | $102.01M | -9.0% |
| Cash & short-term investments | $102.98M | $113.17M | $94.81M | $99.01M | $102.01M | -9.0% |
| Accounts receivable | $125.21M | $147.61M | $195.78M | $151.43M | $140.12M | -15.2% |
| Total current assets | $336.50M | $370.14M | $399.96M | $335.55M | $325.65M | -9.1% |
| Property, plant & equipment | $46.46M | $45.50M | $39.54M | $40.86M | $39.83M | +2.1% |
| Goodwill & intangibles | $1.82B | $1.86B | $1.89B | $1.93B | $1.94B | -1.9% |
| Total assets | $2.35B | $2.39B | $2.46B | $2.42B | $2.41B | -2.1% |
| Total current liabilities | $416.04M | $788.12M | $809.73M | $769.81M | $750.27M | -47.2% |
| Current debt | — | $359.72M | $359.16M | $358.62M | $358.05M | — |
| Long-term debt | $1.29B | $981.66M | $1.04B | $1.06B | $1.10B | +31.6% |
| Total debt | $1.33B | $1.38B | $1.43B | $1.45B | $1.49B | -3.5% |
| Total liabilities | $1.84B | $1.90B | $1.98B | $1.94B | $1.96B | -3.0% |
| Retained earnings | $124.41M | $133.01M | $127.37M | $138.05M | $123.25M | -6.5% |
| Shareholder equity | $506.08M | $498.80M | $478.35M | $477.68M | $452.70M | +1.5% |
| Working capital | -$79.53M | -$417.98M | -$409.77M | -$434.26M | -$424.62M | +81.0% |
| Net tangible assets | -$1.32B | -$1.36B | -$1.41B | -$1.45B | -$1.49B | +3.1% |
| Shares issued | 41.31M | 42.07M | 42.34M | 42.91M | 43.10M | -1.8% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $21.07M | $22.81M | $25.75M | $19.41M | $17.03M | -7.6% |
| Depreciation & amortisation | $36.87M | $35.86M | $35.89M | $39.09M | $38.55M | +2.8% |
| Stock-based compensation | $20.51M | $18.47M | $17.37M | $15.97M | $16.74M | +11.0% |
| Change in working capital | -$4.64M | $12.63M | -$11.87M | $305.00K | -$42.01M | -136.8% |
| Operating cash flow | $78.84M | $98.63M | $62.80M | $73.45M | $30.00M | -20.1% |
| Capital expenditure | -$1.86M | -$2.71M | -$2.86M | -$1.05M | -$495.00K | +31.1% |
| Investing cash flow | -$1.86M | -$2.71M | -$3.43M | -$20.51M | -$495.00K | +31.1% |
| Share buybacks | -$34.69M | -$20.40M | -$40.05M | -$15.00M | -$20.00M | -70.0% |
| Dividends paid | -$159.00K | -$204.00K | -$132.00K | $0 | -$295.00K | +22.1% |
| Financing cash flow | -$85.14M | -$78.88M | -$62.59M | -$57.68M | -$59.23M | -7.9% |
| Free cash flow | $76.97M | $95.92M | $59.94M | $72.39M | $29.50M | -19.8% |
| End cash position | $102.98M | $113.17M | $94.81M | $99.01M | $102.01M | -9.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $247.14M | -1.1% |
| Next quarter | — | — | $249.38M | -1.3% |
| Current year | — | — | $995.75M | +1.8% |
| Next year | — | — | $1.01B | +1.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders2.26%
Held by institutions115.36%
Institutions holding415
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
37.34
-1.45% from price
SMA 20
36.43
+1.02% from price
SMA 50
33.00
+11.50% from price
SMA 100
29.01
+26.84% from price
SMA 200
31.57
+16.56% from price
EMA 12
36.92
-0.33% from price
EMA 26
35.74
+2.95% from price
EMA 50
33.72
+9.12% from price
RSI (14)
56.5
Neutral
MACD (12,26,9)
1.18
Hist -0.21
ATR (14)
0.49
1.32% of price
Realised vol 30D
39.2%
Annualised
Bollinger upper
39.05
20, 2σ
Bollinger lower
33.81
20, 2σ
50 / 200 cross
Golden
33.00 vs 31.57
Trend bias
Above 200
+16.56%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.11
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
39.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-47.3%
Peak to trough
Max drawdown 5Y
-68.1%
Peak to trough
ATR 14
0.49
1.32% of price
Beta (reported)
0.81
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 26 | DA Davidson | MAINTAINED | Buy | Buy |
| Jul 23, 26 | DA Davidson | MAINTAINED | Buy | Buy |
| Jul 1, 26 | DA Davidson | MAINTAINED | Buy | Buy |
| Jul 1, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Jul 1, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Apr 1, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Mar 31, 26 | DA Davidson | MAINTAINED | Buy | Buy |
| Mar 31, 26 | Jefferies | MAINTAINED | Hold | Hold |
| Mar 31, 26 | Wedbush | MAINTAINED | Outperform | Outperform |
| Mar 31, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Mar 25, 26 | DA Davidson | MAINTAINED | Buy | Buy |
| Feb 4, 26 | DA Davidson | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield1.27%
Payout ratio0.00%
Ex-dividend dateAug 30, 2024
Next pay date—
Last split3:2
Split dateJan 31, 2011
Headlines
Billionaire Investor Stanley Druckenmiller Sold Broadcom, Intel, and Micron and Bought Another Chip Stock That Expects to Double Data Center Sales in 2027
Motley Fool · 11m ago
TME Pharma provides update on its activities
GlobeNewswire · 11m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 16m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 16m ago
Board Update
GlobeNewswire · 16m ago
Aegon implements EUR 150 million increase in share buyback program
GlobeNewswire · 16m ago
TOMY's "TOMICA XROSS RESCUE" Diorama-based Short Animation Series to Begin Streaming Aug. 26, 2026
PR Newswire · 16m ago
Holding(s) in Company
GlobeNewswire · 16m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.